Resolution of the Annual General Meeting on the Payment of Dividend for 2025

Date: 26 May 2026

Subject: Resolution of the Annual General Meeting on the Payment of Dividend for 2025

Legal basis: Article 56(1)(2) of the Act on Public Offering – current and periodic information

Text of the report:

The Management Board of Diagnostyka S.A. (the “Company”, the “Issuer”) announces that on 25 May 2026, the Annual General Meeting of Diagnostyka S.A. (the “AGM”) adopted a resolution on the distribution of the Company’s profit for 2025, amounting to PLN 233,111,757.67, as follows:

• PLN 148,528,600.00 was allocated for the payment of a dividend, corresponding to a dividend of PLN 4.40 per share. The number of shares entitled to the dividend is 33,756,500.
• The remaining portion of the profit, amounting to PLN 84,585,157.67, was allocated to the Company’s supplementary capital.

The dividend payout ratio amounts to 59.04% of the amount disclosed in the consolidated financial statements under “net profit attributable to owners of the Parent Company”.

At the same time, the AGM resolved to set the dividend record date as 2 June 2026 and the dividend payment date as 16 June 2026.

Detailed legal basis: § 20(2) of the Regulation of the Minister of Finance of 6 June 2025 on current and periodic information provided by issuers of securities and conditions for recognising as equivalent information required under the laws of a state that is not a Member State.

For the Company:

Jakub Swadźba – President of the Management Board

Marta Rogalska-Kupiec – Vice President of the Management Board